Newgenivf Group Limited Stock Performance
| NIVF Stock | 1.07 0.01 0.94% |
The company secures a Beta (Market Risk) of 0.29, which conveys not very significant fluctuations relative to the market. As returns on the market increase, NewGenIvf Group's returns are expected to increase less than the market. However, during the bear market, the loss of holding NewGenIvf Group is expected to be smaller as well. At this point, NewGenIvf Group has a negative expected return of -2.57%. Please make sure to verify NewGenIvf Group's value at risk, daily balance of power, as well as the relationship between the Daily Balance Of Power and price action indicator , to decide if NewGenIvf Group performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days NewGenIvf Group Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
Last Split Factor 1:20 | Last Split Date 2025-02-11 |
1 | NewGen Engages OSL to Execute Strategic Investment in Digital Assets | 12/19/2024 |
2 | NewGen Announces Strategic Acquisition of MicroSort Reproductive Technology | 01/21/2025 |
3 | NewGenIvf to execute reverse stock split | 01/31/2025 |
4 | NewGen Issues Clarification on Press Release Titled NewGen Receives Continued Nasdaq Listing Approval and Announces New Business Development Director dated Febr... | 02/20/2025 |
5 | NewGenIvf Group receives approval for continued Nasdaq listing shares rise - MSN | 02/21/2025 |
6 | NewGen and BOBCARE Announce Strategic Collaboration to Expand Fertility Services in Kyrgyzstan | 03/03/2025 |
7 | NIVF Stock Plummets to 52-Week Low at 1.02 Amid Market Turbulence - Investing.com | 03/11/2025 |
| Begin Period Cash Flow | 54.7 K |
NewGenIvf |
NewGenIvf Group Relative Risk vs. Return Landscape
If you would invest 847.00 in NewGenIvf Group Limited on December 17, 2024 and sell it today you would lose (740.00) from holding NewGenIvf Group Limited or give up 87.37% of portfolio value over 90 days. NewGenIvf Group Limited is currently does not generate positive expected returns and assumes 12.6763% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than NewGenIvf, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
NewGenIvf Group Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for NewGenIvf Group's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as NewGenIvf Group Limited, and traders can use it to determine the average amount a NewGenIvf Group's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.2024
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | NIVF |
Estimated Market Risk
| 12.68 actual daily | 96 96% of assets are less volatile |
Expected Return
| -2.57 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.2 actual daily | 0 Most of other assets perform better |
Based on monthly moving average NewGenIvf Group is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NewGenIvf Group by adding NewGenIvf Group to a well-diversified portfolio.
NewGenIvf Group Fundamentals Growth
NewGenIvf Stock prices reflect investors' perceptions of the future prospects and financial health of NewGenIvf Group, and NewGenIvf Group fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on NewGenIvf Stock performance.
| Profit Margin | (0.01) % | ||||
| Operating Margin | 0.15 % | ||||
| Current Valuation | 2.07 M | ||||
| Shares Outstanding | 1.7 M | ||||
| Price To Book | 2.00 X | ||||
| Price To Sales | 0.99 X | ||||
| Revenue | 5.14 M | ||||
| Gross Profit | 1.48 M | ||||
| EBITDA | 384.31 K | ||||
| Net Income | (690.85 K) | ||||
| Total Debt | 332.55 K | ||||
| Book Value Per Share | (12.98) X | ||||
| Cash Flow From Operations | (857.36 K) | ||||
| Earnings Per Share | 0.26 X | ||||
| Market Capitalization | 5.64 M | ||||
| Total Asset | 1.65 M | ||||
| Retained Earnings | (5.67 M) | ||||
| Working Capital | 79 K | ||||
About NewGenIvf Group Performance
By analyzing NewGenIvf Group's fundamental ratios, stakeholders can gain valuable insights into NewGenIvf Group's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if NewGenIvf Group has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if NewGenIvf Group has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 12.01 | 12.61 | |
| Return On Tangible Assets | (0.48) | (0.46) | |
| Return On Capital Employed | 0.07 | 0.08 | |
| Return On Assets | (0.48) | (0.46) | |
| Return On Equity | (0.05) | (0.05) |
Things to note about NewGenIvf Group performance evaluation
Checking the ongoing alerts about NewGenIvf Group for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for NewGenIvf Group help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| NewGenIvf Group generated a negative expected return over the last 90 days | |
| NewGenIvf Group has high historical volatility and very poor performance | |
| NewGenIvf Group has some characteristics of a very speculative penny stock | |
| The company reported the previous year's revenue of 5.14 M. Net Loss for the year was (690.85 K) with profit before overhead, payroll, taxes, and interest of 1.48 M. | |
| NewGenIvf Group generates negative cash flow from operations | |
| Latest headline from news.google.com: NIVF Stock Plummets to 52-Week Low at 1.02 Amid Market Turbulence - Investing.com |
- Analyzing NewGenIvf Group's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether NewGenIvf Group's stock is overvalued or undervalued compared to its peers.
- Examining NewGenIvf Group's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating NewGenIvf Group's management team can have a significant impact on its success or failure. Reviewing the track record and experience of NewGenIvf Group's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of NewGenIvf Group's stock. These opinions can provide insight into NewGenIvf Group's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for NewGenIvf Stock analysis
When running NewGenIvf Group's price analysis, check to measure NewGenIvf Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NewGenIvf Group is operating at the current time. Most of NewGenIvf Group's value examination focuses on studying past and present price action to predict the probability of NewGenIvf Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NewGenIvf Group's price. Additionally, you may evaluate how the addition of NewGenIvf Group to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |